•  
  •  
  •  
  •  

2026-03-27 05:18:35

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • EaseMyTrip Enters Exclusive Partnership with MSTC Ltd. to Power Travel Services for Govt Sector
  • Sundaram-Clayton Completes Rs 558.62 Cr Land Sale
  • 3i Infotech Digital BPS Ltd receives order from Mahanagar Gas Ltd
  • AZAD Engineering Ltd signs long term contract with Mitsubishi Heavy Industries Ltd
  • PNGS Gargi Fashion Jewellery Ltd opens new store in Pune

Keywords Selected:  USFDA

Stock Report

  • Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets
  • Glenmark Therapeutics Inc., USA launches Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)
  • Eugia Pharma Specialities Ltd receives OAI classification from USFDA for Unit 2
  • Caplin Steriles gets USFDA approval for Potassium Phosphates Injection
  • Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg
  • Unit-IV of APL Healthcare Ltd classified as VAI by the US FDA
  • Lupin Ltd gets two observations from USFDA for Ankleshwar facility
  • Granules India's Packaging Facility in US gets FDA EIR with No Action Indicated Status
  • Gland Pharma Ltd receives tentative approval from USFDA
  • Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity
  • Caplin Steriles gets USFDA approval for Desmopressin Acetate Injection
  • Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
  • Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltd., Shameerpet
  • Lupin Receives EIR from US FDA for its Goa Facility
  • Eugia Pharma receives USFDA Approval for Everolimus Tablets
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Efinaconazole Topical Solution, 10%
  • Caplin Steriles gets USFDA approval for Sodium Phosphates Injection
  • Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution, 10 mg/mL
  • Closure of USFDA inspection at Zydus' Injectable plant at Ahmedabad
  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • Zydus receives final approval from USFDA for Bosentan tablets for oral suspension, 32 mg
  • USFDA inspection at the manufacturing facility of Enzene Biosciences Limited
  • Alembic Pharmaceuticals gets USFDA nod for generic Parkinson's disease treatment tablets

Latest Post

  • EaseMyTrip Enters Exclusive Partnership with MSTC Ltd. to Power Travel Services for Govt Sector
  • Sundaram-Clayton Completes Rs 558.62 Cr Land Sale
  • 3i Infotech Digital BPS Ltd receives order from Mahanagar Gas Ltd
  • AZAD Engineering Ltd signs long term contract with Mitsubishi Heavy Industries Ltd
  • PNGS Gargi Fashion Jewellery Ltd opens new store in Pune


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025